BioDrone Therapeutics Inc.
  • Home
  • About Us
  • More
    • Home
    • About Us
BioDrone Therapeutics Inc.
  • Home
  • About Us

Overview

BioDrone Therapeutics Inc.

BioDrone Therapeutic Inc., a property of MDimune, was established in Seattle, WA, in 2019. The company seeks to facilitate global business collaborations for the BioDrone™ platform technology. Based on its immense therapeutic potential, the company strives to expedite the commercialization of BioDrone™ technology through partnerships with global pharmaceutical companies to extend its therapeutic application and through the integration of advanced technologies from a diverse range of therapeutic areas into the platform.

MDimune Inc.

MDimune Inc., founded in 2015, is a biotech company headquartered in Seoul, Korea, and has been dedicated to the development of the innovative therapeutic platform BioDrone™. The novel BioDrone™ platform technology uses cell-derived vesicles to overcome the limitations of existing cell therapies or achieve target-specific drug delivery. BioDrone™ platform technology is patented in the US, Europe, China, Japan, and Korea. MDimune is actively pursuing business partnerships with biotech and pharmaceutical companies for the potential application of the BioDrone™ technology for various unmet medical needs.

Visit MDimune's website

Contact Us

Please leave a message!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioDrone Therapeutics Inc.

4000 Mason Rd #300, Seattle, WA 98195, USA

biodrone@mdimune.com

Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.

  • Contact